CD19 and colorectal carcinoma: To further identify the source of the cellular origins of IL-38 production within colorectal regional nodes of CRC patients, sections were double stained with fluorescence-labelled anti-IL-38 and antibodies against CD3, CD19, CD138, or CD68 (Figure 2).